Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07497867Recruiting

Long-term Prospective Study of Korean CADASIL Patients

Role: collaborator

NCT04719936Not ApplicableCompleted

Superior and Inferior Capsulotomy in Bipolar Hemiarthroplasty Using Posterior Approach

Role: collaborator

NCT06730893Not ApplicableNot Yet Recruiting

Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer

Role: collaborator

NCT06229405Recruiting

Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data

Role: collaborator

NCT04536428Not ApplicableUnknown

ClearEndoclip Versus EZ Clip for Upper Gastrointestinal Ulcer Bleeding

Role: collaborator

All 5 trials loaded